Department of Innovation, NuProbe USA, Houston, TX 77054, USA.
Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, Shanghai 200032, China.
Nucleic Acids Res. 2024 Sep 23;52(17):e81. doi: 10.1093/nar/gkae683.
Quantitative PCR (qPCR) is the gold standard for detection and quantitation of known DNA targets, but the scarcity of spectrally distinct fluorophores and filter sets limits the number of detectable targets. Here, we introduce color cycle multiplex amplification (CCMA) to significantly increase the number of detectable DNA targets in a single qPCR reaction using standard instrumentation. In CCMA, presence of one DNA target species results in a pre-programmed pattern of fluorescence increases. This pattern is distinguished by cycle thresholds (Cts) through rationally designed delays in amplification. For example, we design an assay wherein Staphylococcus aureus sequentially induces FAM, then Cy5.5, then ROX fluorescence increases with more than 3 cycles between each signal. CCMA offers notably higher potential for multiplexing because it uses fluorescence permutation rather than combination. With 4 distinct fluorescence colors, CCMA theoretically allows the detection of up to 136 distinct DNA target sequences using fluorescence permutation. Experimentally, we demonstrated a single-tube qPCR assay screening 21 sepsis-related bacterial DNA targets in samples of blood, sputum, pleural effusion and bronchoalveolar lavage fluid, with 89% clinical sensitivity and 100% clinical specificity, showing its potential as a powerful tool for advanced quantitative screening in molecular diagnostics.
实时荧光定量聚合酶链反应(qPCR)是检测和定量已知 DNA 靶标的金标准,但光谱上明显不同的荧光团和滤光片的稀缺限制了可检测靶标的数量。在这里,我们介绍了颜色循环多重扩增(CCMA),它使用标准仪器在单个 qPCR 反应中显著增加了可检测的 DNA 靶标的数量。在 CCMA 中,一种 DNA 靶标物质的存在会导致预先编程的荧光增加模式。通过合理设计的扩增延迟,可以通过循环阈值(Ct)来区分这种模式。例如,我们设计了一种测定方法,其中金黄色葡萄球菌依次诱导 FAM、然后 Cy5.5、然后 ROX 荧光增加,每个信号之间有超过 3 个循环的延迟。CCMA 提供了更高的多重化潜力,因为它使用荧光置换而不是组合。通过 4 种不同的荧光颜色,CCMA 理论上允许通过荧光置换检测多达 136 种不同的 DNA 靶序列。在实验中,我们在血液、痰、胸腔积液和支气管肺泡灌洗液样本中进行了一项单管 qPCR 检测 21 种与脓毒症相关的细菌 DNA 靶标,其临床灵敏度为 89%,临床特异性为 100%,表明其作为分子诊断中高级定量筛选的有力工具的潜力。